President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni Connection
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowWays to GiveHigh Hopes FundGet InvolvedEventsCorporate & Foundation SupportPlanned GivingPhilanthropy Team

Joslin Institute for Technology Translation


Joslin Institute for Technology Translation (JITT) is focused on leveraging the potential of technology with the introduction of clinical solutions and digital health to improve the lives of people with diabetes. JITT pairs Joslin Diabetes Center’s clinical expertise with industry to enhance the development of new and clinically effective technologies and digital health tools; JITT is uniquely positioned to provide clinical insight for medical devices, technologies, and strategies for cost-efficient solutions that improve diabetes care and outcomes.


Our Mission

   Create and offer physician-designed and patient-tested decision support tools for improved solutions in glucose and insulin management.

   Be a powerful voice with offering digital health strategies to improve diabetes care with a cost-effective approach — collaborating with numerous medical device and technology organizations.

   Create individualized, confidential collaborations with industry partners to offer new solutions that advance the monitoring and treatment of diabetes via new technologies.

   Pioneer innovative education and training programs that optimize decision-making processes and the adoption of best-in-class technologies for healthcare professionals and patients.